To describe the surgical technique and considerations for performing auditory brainstem implants (ABIs) in pediatric patients, highlighting their significance in addressing profound hearing loss.
Key Findings:
Three ABI systems are commercially available: Med El CONCERTO, Oticon Digisonic SP, and Cochlear Nucleus ABI541, each with unique features that cater to different patient needs.
The retrosigmoid approach is favored for pediatric ABIs due to its advantages over the translabyrinthine approach, particularly in preserving inner ear structures.
Intraoperative monitoring techniques, including EABR, are crucial for optimal implant placement, ensuring the best possible outcomes for patients.
Interpretation:
The described technique emphasizes the importance of careful anatomical navigation and monitoring to ensure successful implantation and function of ABIs in children, potentially improving their quality of life.
Limitations:
The article does not address long-term outcomes or complications associated with ABI surgery, which are critical for understanding the full impact of the procedure.
Specific patient selection criteria and postoperative care protocols are not detailed, which are essential for guiding clinical practice.
Conclusion:
The retrosigmoid approach for pediatric ABI surgery is effective and allows for careful placement of the device while minimizing risks to surrounding structures, underscoring its importance in pediatric otology.
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
